MedPath

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Phase 1
Completed
Conditions
Diabetic Macular Edema
Registration Number
NCT00308542
Lead Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Brief Summary

This study will evaluate the safety and efficacy of intravitreal implant of dexamethasone for the treatment of diabetic edema.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Diabetic macular edema
  • Criteria for visual acuity and macular thickness are met
Exclusion Criteria
  • History of glaucoma
  • Known steroid-responder
  • Use of systemic steroids
  • Use of Warfarin/Heparin
  • Other protocol-defined exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath